Closing Bell: Knight Therapeutics Inc down on Wednesday (GUD)

In today's trading, Knight Therapeutics Inc shares closed at $5.54 after opening the day at $5.60. It traded at a low of $5.50 to a high of $5.61.

Shares dipped -0.18 percent from the previous day's close of $5.55.

During the day across North America, the TSX Composite closed -0.45% at 21880.95, the S&P 500 closed -0.77% at 5199.50, the Dow Jones Industrial Average closed -0.60% at 38763.45 and the Nasdaq Composite closed 1.03% at 16366.85.

Knight Therapeutics Inc traded under GUD on the Toronto Stock Exchange (TSX).

Trading volume was 67,029 on 197 total trades. On average, Knight Therapeutics Inc has traded 54,049 shares in the last five days and 65,156 year-to-date.

The TSX overall saw 1,858 price advancers against 3,319 declines and 108 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, the shares have advanced 16.14 percent in the last year, while they have advanced 6.74% since the start of 2024.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $562.64 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Knight Therapeutics Inc's average recommendation is "Moderate Buy" based on 4.00 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..